Fairvalue-Calculator Fairvalue-Calculator
EN DE

BIO-FD&C Co (251120) Fair Value & Analysis

Healthcare · KR · Market cap 80.3B KRW

Price8,200 KRW
Fair Value10,116 KRW
Upside+23.4%
Quality95/100
Evidence: High Range 7,696 KRW – 13,430 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

BIO-FD&C Co (251120) currently trades at 8,200 KRW, while our model-based Fair Value estimate is 10,116 KRW — implying the stock looks roughly 23.4% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

BIO-FD&C Co.,Ltd. develops active ingredients for anti-aging cosmetics in South Korea. It offers plant cell, peptide, natural extract, and biomolecule products for wrinkle improvement/skin regeneration, skin brightening, acne, skin irritation, wound healing, scalp improvement, skin moisturizing, fine dust, hair loss improvement, pores, lifting, whitening, skin texture, anti-inflammation/skin soothing, and anti-oxidation. The company was founded in 2005 and is headquartered in Incheon, South Korea.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -32% Regeneron Pharmaceuticals, Inc (REGN) -4% UCB SA (UCB) -28% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +1% Alnylam Pharmaceuticals, Inc (ALNY) -82%

Frequently asked questions

Is BIO-FD&C Co (251120) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 10,116 KRW versus a price of 8,200 KRW — about +23% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 251120?
Our 21-model fair value for BIO-FD&C Co is 10,116 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 8,200 KRW.
What is the quality score of 251120?
BIO-FD&C Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.